Source: Myeloma – Hematology Advisor
Researchers sought to determine whether a different administration of daratumumab would lead to shorter clinic times for patients with multiple myeloma.
Read More
by | Mar 15, 2023 | Myeloma News | 0 comments
Source: Myeloma – Hematology Advisor
Researchers sought to determine whether a different administration of daratumumab would lead to shorter clinic times for patients with multiple myeloma.
Read More